Your browser doesn't support javascript.
loading
Is it time to consider population screening for fracture risk in postmenopausal women? A position paper from the International Osteoporosis Foundation Epidemiology/Quality of Life Working Group.
Chotiyarnwong, P; McCloskey, E V; Harvey, N C; Lorentzon, M; Prieto-Alhambra, D; Abrahamsen, B; Adachi, J D; Borgström, F; Bruyere, O; Carey, J J; Clark, P; Cooper, C; Curtis, E M; Dennison, E; Diaz-Curiel, M; Dimai, H P; Grigorie, D; Hiligsmann, M; Khashayar, P; Lewiecki, E M; Lips, P; Lorenc, R S; Ortolani, S; Papaioannou, A; Silverman, S; Sosa, M; Szulc, P; Ward, K A; Yoshimura, N; Kanis, J A.
Afiliación
  • Chotiyarnwong P; Department of Oncology & Metabolism, Mellanby Centre for Musculoskeletal Research, MRC Versus Arthritis Centre for Integrated Research in Musculoskeletal Ageing, University of Sheffield, Sheffield, UK.
  • McCloskey EV; Department of Orthopaedic Surgery, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Harvey NC; Department of Oncology & Metabolism, Mellanby Centre for Musculoskeletal Research, MRC Versus Arthritis Centre for Integrated Research in Musculoskeletal Ageing, University of Sheffield, Sheffield, UK. e.v.mccloskey@sheffield.ac.uk.
  • Lorentzon M; Centre for Metabolic Bone Diseases, Northern General Hospital, University of Sheffield, Herries Road, Sheffield, S5 7AU, UK. e.v.mccloskey@sheffield.ac.uk.
  • Prieto-Alhambra D; MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton, UK.
  • Abrahamsen B; University of Gothenburg, Gothenburg, Sweden.
  • Adachi JD; Australian Catholic University, Melbourne, Australia.
  • Borgström F; Oxford NIHR Biomedical Research Centre, University of Oxford, Windmill Road, Oxford, OX3 7LD, UK.
  • Bruyere O; GREMPAL (Grup de Recerca en Malalties Prevalents de L'Aparell Locomotor) Research Group, CIBERFes and Idiap Jordi Gol Primary Care Research Institute, Universitat Autònoma de Barcelona and Instituto de Salud Carlos III, Gran Via de Les Corts Catalanes, 591 Atico, 08007, Barcelona, Spain.
  • Carey JJ; Department of Clinical Research, Odense Patient Data Exploratory Network, University of Southern Denmark, Odense, Denmark.
  • Clark P; Department of Medicine, Holbæk Hospital, Holbæk, Denmark.
  • Cooper C; Department of Medicine, Michael G DeGroote School of Medicine, St Joseph's Healthcare-McMaster University, Hamilton, ON, Canada.
  • Curtis EM; Quantify Research, Stockholm, Sweden.
  • Dennison E; Department of Learning, Informatics, Management and Ethics (LIME), Karolinska Institutet, Stockholm, Sweden.
  • Diaz-Curiel M; WHO Collaborating Center for Public Health Aspects of Musculo-Skeletal Health and Ageing, Division of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium.
  • Dimai HP; School of Medicine, National University of Ireland Galway, Galway, Ireland.
  • Grigorie D; Department of Rheumatology, Galway University Hospitals, Galway, Ireland.
  • Hiligsmann M; Clinical Epidemiology Unit of Hospital Infantil de México Federico Gómez-Faculty of Medicine, Universidad Nacional Autónoma de México, UNAM, Mexico City, Mexico.
  • Khashayar P; MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton, UK.
  • Lewiecki EM; MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton, UK.
  • Lips P; MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton, UK.
  • Lorenc RS; Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.
  • Ortolani S; Department of Internal Medicine, Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria.
  • Papaioannou A; Carol Davila University of Medicine, Bucharest, Romania.
  • Silverman S; Department of Endocrinology & Bone Metabolism, National Institute of Endocrinology, Bucharest, Romania.
  • Sosa M; Department of Health Services Research, CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, the Netherlands.
  • Szulc P; Center for Microsystems Technology, Imec and Ghent University, 9050, Ghent, Belgium.
  • Ward KA; New Mexico Clinical Research & Osteoporosis Center, Albuquerque, NM, USA.
  • Yoshimura N; Department of Internal Medicine, Endocrine Section & Amsterdam Public Health Research Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
  • Kanis JA; Multidisciplinary Osteoporosis Forum, SOMED, Warsaw, Poland.
Arch Osteoporos ; 17(1): 87, 2022 06 28.
Article en En | MEDLINE | ID: mdl-35763133
ABSTRACT
The IOF Epidemiology and Quality of Life Working Group has reviewed the potential role of population screening for high hip fracture risk against well-established criteria. The report concludes that such an approach should strongly be considered in many health care systems to reduce the burden of hip fractures.

INTRODUCTION:

The burden of long-term osteoporosis management falls on primary care in most healthcare systems. However, a wide and stable treatment gap exists in many such settings; most of which appears to be secondary to a lack of awareness of fracture risk. Screening is a public health measure for the purpose of identifying individuals who are likely to benefit from further investigations and/or treatment to reduce the risk of a disease or its complications. The purpose of this report was to review the evidence for a potential screening programme to identify postmenopausal women at increased risk of hip fracture.

METHODS:

The approach took well-established criteria for the development of a screening program, adapted by the UK National Screening Committee, and sought the opinion of 20 members of the International Osteoporosis Foundation's Working Group on Epidemiology and Quality of Life as to whether each criterion was met (yes, partial or no). For each criterion, the evidence base was then reviewed and summarized. RESULTS AND

CONCLUSION:

The report concludes that evidence supports the proposal that screening for high fracture risk in primary care should strongly be considered for incorporation into many health care systems to reduce the burden of fractures, particularly hip fractures. The key remaining hurdles to overcome are engagement with primary care healthcare professionals, and the implementation of systems that facilitate and maintain the screening program.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Osteoporosis / Fracturas de Cadera Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Arch Osteoporos Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Osteoporosis / Fracturas de Cadera Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Arch Osteoporos Año: 2022 Tipo del documento: Article